Vesalius Biocapital Vesalius Biocapital Partners

Vesalius Biocapital offers venture capital. To young European innovative life science companies. Vesalius Biocapital Partners Sàrl. 1B rue Thomas Edison. T 352 26 84 56 82. Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. We have contributed to developing 20 companies since inception. Our companies are based in Europe allowing easy interaction with management. Monday, August 10, 2015. Humedics receives ISO 13485 certification.

OVERVIEW

The website vesaliusbiocapital.com presently has an average traffic ranking of zero (the lower the more traffic). We have parsed eleven pages within the web site vesaliusbiocapital.com and found fourteen websites associating themselves with vesaliusbiocapital.com. There is two contacts and locations for vesaliusbiocapital.com to help you reach them. The website vesaliusbiocapital.com has been online for eight hundred and ninety-seven weeks, fifteen days, two hours, and forty-three minutes.
Pages Parsed
11
Links to this site
14
Contacts
2
Addresses
2
Online Since
Sep 2007

VESALIUSBIOCAPITAL.COM TRAFFIC

The website vesaliusbiocapital.com is seeing diverging levels of traffic for the duration of the year.
Traffic for vesaliusbiocapital.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for vesaliusbiocapital.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for vesaliusbiocapital.com

Date Range

All time
This Year
Last Year
Last Month

VESALIUSBIOCAPITAL.COM HISTORY

The website vesaliusbiocapital.com was first documented on September 04, 2007. It was last updated on the date of September 04, 2013. This web page will go back on the market on the date of September 03, 2014. It is now eight hundred and ninety-seven weeks, fifteen days, two hours, and forty-three minutes old.
REGISTERED
September
2007
UPDATED
September
2013
EXPIRED
September
2014

SPAN

17
YEARS
2
MONTHS
13
DAYS

LINKS TO WEBSITE

Apitope Developing new therapies for the treatment of autoimmune and allergic diseases

Developing new therapies for the treatment of autoimmune and allergic diseases. Apitope Receives Orphan Designation in the European Union for ATX-F8-117 for the .

Complix Home - Complix

Exploring a new universe of targets. Looking beyond the horizon,. Exploring a new universe of targets. Our Alphabody platform has the potential to transform. Intracellular PPIs represent an attractive class of targets because they are implicated in many importa.

eaccfrance European American Chamber of Commerce

Intellectual Property and Innovation Committee. New chapters are being developed in other US and European cities.

WBC Incubator

Avec un projet de société. WBC est également présent c.

WHAT DOES VESALIUSBIOCAPITAL.COM LOOK LIKE?

Desktop Screenshot of vesaliusbiocapital.com Mobile Screenshot of vesaliusbiocapital.com Tablet Screenshot of vesaliusbiocapital.com

CONTACTS

VALUE FOR GROWTH

Abbeloos Edouard

Nieuwstraat 16

TERVUREN, 3080

BE

UniWeb BVBA

Rudi Tielemans

's Herenweg 16

Meise, 1860

BE

VESALIUSBIOCAPITAL.COM SERVER

I revealed that a lone page on vesaliusbiocapital.com took one thousand two hundred and sixty-six milliseconds to come up. Our web crawlers could not discover a SSL certificate, so in conclusion our web crawlers consider this site not secure.
Load time
1.266 sec
SSL
NOT SECURE
IP
85.119.185.128

NAME SERVERS

ns1.uniweb.be
ns2.uniweb.be

WEBSITE ICON

SERVER SOFTWARE

We identified that vesaliusbiocapital.com is employing the Apache operating system.

SITE TITLE

Vesalius Biocapital Vesalius Biocapital Partners

DESCRIPTION

Vesalius Biocapital offers venture capital. To young European innovative life science companies. Vesalius Biocapital Partners Sàrl. 1B rue Thomas Edison. T 352 26 84 56 82. Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. We have contributed to developing 20 companies since inception. Our companies are based in Europe allowing easy interaction with management. Monday, August 10, 2015. Humedics receives ISO 13485 certification.

PARSED CONTENT

The website has the following on the web page, "To young European innovative life science companies." I analyzed that the web site also said " T 352 26 84 56 82." They also stated " Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. We have contributed to developing 20 companies since inception. Our companies are based in Europe allowing easy interaction with management. Monday, August 10, 2015. Humedics receives ISO 13485 certification."

SEE OTHER BUSINESSES

Home Vesalius

Twitter feed for The Fabric of the Human Body. Facebook Page for The Fabric of the Human Body. Find information on Events and Exhibitions. Related to anatomy, Vesalius and. The Fabric of the Human Body. Get the full story on the Fabrica. Counted among the greatest books and artworks in publishing history, and its creator Vesalius.

Vesalius Health

All prices are in All prices are in USD. Gel Insoles and Heel Cushions. Kinesio Fancut Beige - 2 inch 5 cm width with 5 Tape Tails. Breast Cancer Awareness Lacrosse Athlete Pack. Breast Cancer Awareness Golf Athlete Pack.

Home Vesaliusinstituut

In associatie met Atheneum Centrum en MS Bredene. In associatie met Atheneum Centrum en MS Bredene. Info and inschrijvingen in de zomervakantie. Leffingestraat 1 - 059 70 68 70. Rijselstraat 3 - 0498 92 18 91. Keramiekstraat 80 - 09 243. Graaf Karel De Goedelaan 7 - 0499 69 11 62. Noordlaan 32 - 0492 34 19 94. Ninovestraat 169 - 0477 25 41 89. Rue de Ninove 169 - 0477 74 81 49.

Mood Indigo

Jueves, 3 de julio de 2014. Martes, 22 de abril de 2014. Lo lei en un taller, pero podria estar en el servicio de urgencias. Sábado, 19 de abril de 2014. 000 perros usan las calles de París para aliviar sus intestinos con más de veinte toneladas de excrementos. Y cada año,mas de 600 personas acaban en el hospital, tras resbalarse con ellos y caerse. Buscar entrada en este blog.